Ovarian Function Maintenance Challenges—Recent Development Focus

May 25, 2026

Code to Conception

Daily micro-protocols for the 90-day miracle window

| May 25, 2026 |

🔬 Pre-Bump Biology  

Astaxanthin isn’t just another antioxidant—it embeds directly into ovarian and mitochondrial membranes, switches on the Nrf2 defense system, and dampens NF-κB–driven inflammation. In women with PCOS, endometriosis, or poor ovarian response, RCTs show clear gains in mature (MII) oocytes and higher-quality embryos within 8–12 weeks.

Meet your pocket fertility advocate
HeyNellee helps you walk into every appointment with confidence—explaining your labs, stress, sleep, and hormones through 10,000+ verified scientific sources (many from 2025). So when your doctor says “let’s jump straight to IVF,” you can calmly show the evidence and ask, “Can we try this first?”
• Get real-time explanations of your labs & symptoms
• Pull up studies during appointments—instantly
• Avoid unnecessary interventions & regain peace of mind
Try HeyNellee — Free Early Access →
Built from 10,980+ peer-reviewed studies • Private, ad-free, science-first

🧬 Protocol Drop  

Today’s 1-Step Protocol:
Take 6–12 mg natural astaxanthin (microalgal, oil-based softgel) with your largest fat-containing meal of the day.
• Use 6 mg/day as a baseline.
• Increase to 12 mg/day if you’re ≥35 or have PCOS, endometriosis, or prior low egg yield.
Start at least 8–12 weeks before IVF/ICSI or serious conception attempts.

📚 Glossary Pop  

Nrf2 Pathway:
Nrf2 is your cell’s emergency antioxidant commander. When activated, it raises levels of protective enzymes like SOD, CAT, and GPx that guard eggs and granulosa cells from oxidative injury. Strong Nrf2 signaling is linked to better egg maturity, healthier follicles, and improved embryo quality.

Send this issue to your partner—antioxidant timing is one of the easiest wins you can stack together today.
P.S. Tomorrow Teaser
Why are modern sperm and eggs collapsing under pressures our grandparents never faced? Tomorrow we unpack the newest findings on multiplying environmental threats—and the breakthrough science revealing how toxins are reshaping human reproduction.

Want to learn more?

Brendler, T., & Williamson, E. M. (2019). Astaxanthin: How much is too much? A safety review. Phytotherapy research : PTR, 33(12), 3090–3111. https://doi.org/10.1002/ptr.6514

Gharaei, R., Alyasin, A., Mahdavinezhad, F., Samadian, E., Ashrafnezhad, Z., & Amidi, F. (2022). Randomized controlled trial of astaxanthin impacts on antioxidant status and ART outcomes in women with polycystic ovarian syndrome. Journal of Assisted Reproduction and Genetics, 39(4), 995–1008. https://doi.org/10.1007/s10815-022-02432-0

Rostami, S., Alyasin, A., Saedi, M., Nekoonam, S., Khodarahmian, M., Moeini, A., & Amidi, F. (2023). Astaxanthin ameliorates inflammation, oxidative stress, and reproductive outcomes in endometriosis patients undergoing assisted reproduction: A randomized, triple-blind placebo-controlled clinical trial. Frontiers in Endocrinology, 14, 1144323. https://doi.org/10.3389/fendo.2023.1144323

Shafie, A., Aleyasin, A., Saffari, M., Saedi, M., Rostami, S., Rezayi, S., Mohammadi, S. D., & Amidi, F. (2024). Astaxanthin improves assisted reproductive technology outcomes in poor ovarian responders through alleviating oxidative stress, inflammation, and apoptosis: A randomized clinical trial. Journal of Ovarian Research, 17(1), 212. https://doi.org/10.1186/s13048-024-01537-7